Lynne Canne Bannen

This inventor holds 27 USPTO granted patents and 22 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Kinase Modulators. Top assignees: Exelixis, Inc., Assembly Biosciences, Inc., Symphony Evolution, Inc.. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lynne Canne Bannen. Retrieved from https://idiyas.com/inventor/lynne-canne-bannen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 22)

% Patents Active = 66.7

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 9.1

ph-index = 9

Forward Citations = 440(Granted Patents)

Location History:

Lucerne, CA (US) (2013 - 2014)
Pacifica, CA (US) (2001 - 2018)
New Castle, IN (US) (2021)
Carmel, IN (US) (2021 - 2023)
Novato, CA (US) (2023)
South San Francisco, CA (US) (2024)

Company Filing History:

Assembly Biosciences, Inc.

patents

2 out of 10

Symphony Evolution, Inc.

patents

4. 1 out of 3,745

Bristol-Myers Squibb Compnay

patents

5. 1 out of 1,208

Scripps Research Institute

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

Kinase Modulators

HBV Treatment

Phosphatidylinositol Inhibitors

Pyridone Compounds

C-Met Modulators

Pyrrole Derivatives

ADAM-10 Inhibitors

5-Membered Heteroaryl Compounds

Tie-2 Modulators

Chemical Ligation

Hepatitis B Core Protein

RORγ Modulators

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12503438 - Compounds for the treatment of kinase-dependent disorders (2025-12-23),

2. 12371428 - Pyridone compounds and methods of use (2025-07-29),

3. 12195475 - Compounds for the treatment of kinase-dependent disorders (2025-01-14),

4. 12030869 - 5-membered heteroaryl carboxamide compounds for treatment of HBV (2024-07-09),

5. 11708367 - Compounds for the treatment of kinase-dependent disorders (2023-07-25),

6. 11673897 - Compounds for the treatment of kinase-dependent disorders (2023-06-13),

7. 11560370 - 5-membered heteroaryl carboxamide compounds for treatment of HBV (2023-01-24),

8. 11542259 - Compounds for the treatment of kinase-dependent disorders (2023-01-03),

9. 11124482 - C-met modulators and methods of use (2021-09-21),

10. 10987360 - Hepatitis B core protein modulators (2021-04-27),

11. 10035790 - RORγ modulators (2018-07-31),

12. 9174947 - c-Met modulators and methods of use (2015-11-03),

13. 8889664 - Phosphatidylinositol 3-kinase inhibitors and methods of their use (2014-11-18),

14. 8497284 - C-met modulators and method of use (2013-07-30),

15. 8476298 - c-Met modulators and method of use (2013-07-02),

Title: The Innovative Mind of Lynne Canne Bannen

Introduction: Lynne Canne Bannen, a talented inventor hailing from Pacifica, CA (US), is known for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Lynne Canne Bannen has recently been granted patents for his cutting-edge inventions in the field of renewable energy storage systems and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Lynne Canne Bannen has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has revolutionized industries such as clean energy, transportation, and environmental sustainability.

Collaborations: Throughout his career, Lynne Canne Bannen has collaborated with leading research institutions, universities, and technology companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Lynne Canne Bannen's passion for innovation and his relentless pursuit of excellence have cemented his reputation as a trailblazer in the world of inventions. His contributions continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.